Thomas Tran
Family Medicine · Wichita, KSNPI 1811959190
Payments from drug & device makers
Across 500 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Amgen$2K
- Amarin Pharma, Inc.$980
- Novo Nordisk$948
- Nestle Healthcare Nutrition Inc.$602
- AbbVie$524
- plus $3K from 22 others
What the payments were for
- Food & beverage$10,585100%
- Education$480%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 69 | $2,533 |
| Amgen(2 entities) | 77 | $1,736 |
| Amarin Pharma, Inc. | 54 | $980 |
| Novo Nordisk | 44 | $948 |
| Nestle Healthcare Nutrition Inc. | 39 | $602 |
| AbbVie(2 entities) | 20 | $524 |
| Lilly USA, LLC | 30 | $428 |
| Boehringer Ingelheim | 14 | $378 |
| Pfizer | 32 | $318 |
| Kowa Pharmaceuticals America, Inc. | 9 | $257 |
| Sunovion Pharmaceuticals Inc. | 23 | $246 |
| Bayer | 6 | $198 |
| Astellas Pharma US Inc | 10 | $160 |
| Mylan Specialty L.p. | 4 | $157 |
| Zyla Life Sciences, Inc. | 19 | $129 |
| GSK | 9 | $127 |
| Exact Sciences | 1 | $125 |
| Merck | 8 | $113 |
| Aimmune Therapeutics, Inc. | 6 | $110 |
| Gilead | 6 | $102 |
| Radius Health, Inc. | 1 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Sanofi-aventis U.S. LLC | 5 | $85 |
| Eisai Inc. | 3 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Abbott | 2 | $45 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,632 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 21 | $48,067 |
| FarxigaDapagliflozin Propanediol | 28 | $34,480 |
| JardianceEmpagliflozin | 27 | $33,248 |
| MyrbetriqMirabegron | 25 | $25,364 |
| EliquisApixaban | 16 | $23,008 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $22,795 |
| JanuviaSitagliptin Phosphate | 18 | $12,440 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $12,147 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $9,585 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $7,738 |
| Humalog Kwikpen U-100Insulin Lispro | 15 | $3,118 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 156 | $3,031 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 16 | $2,823 |
| Clobetasol Propionate | 19 | $2,082 |
| Novolog FlexpenInsulin Aspart | 15 | $2,046 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus | $948 | $48,06721 claims |
| AstraZenecaFarxiga | $2,533 | $34,48028 claims |
| Boehringer IngelheimJardiance | $378 | $33,24827 claims |
| Astellas Pharma US IncMyrbetriq | $160 | $25,36425 claims |
| PfizerEliquis | $318 | $23,00816 claims |
| MerckJanuvia | $113 | $12,44018 claims |
| GSKBreo Ellipta | $127 | $9,58524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Terry PolingWichita$24.2M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Brandon AllemanWichita$3M
- Tracy KleinWichita$2.7M
- William SimonWichita$1.1M
- Tana GoeringWichita$1.1M
- Gregory LakinWichita$897K
- Timothy KoehlerWichita$675K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.